Three participants from Cohort 1 (R101, R102, and R107) showed moderate-to-severe ALT/AST elevations, but no change in bilirubin, with relatively high-peak parasitemia levels (147,074–378,077 parasites/mL). The gene discussed is GPT; the disease is parasitic infectious disease.